This article provides a practical overview of GMP regulations in 2026, covering FDA 21 CFR 210/211, EU GMP guidelines EudraLex Volume 4, and WHO expectations. It explains inspection trends, audit readiness, and regulatory compliance gaps in pharmaceutical manufacturing systems.
